A Bioengineered MSC-EVs nanoplatform restores VCP-dependent mitophagy and promotes regeneration in steatotic livers via the miR-423-5p/SAA1 axis
Post-hepatectomy liver failure (PHLF) in steatotic livers presents a critical clinical challenge, with mortality rates exceeding 30%, primarily due to defective mitophagy and dysregulated lipid metabolism. Currently, effective targeted therapies remain elusive. Through transcriptomic analysis of partial hepatectomy models, we identified Serum Amyloid A1 (SAA1) as a key pathogenic factor driving regeneration failure in fatty livers. To address this, we developed a bioengineered nanoplatform using mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) enriched with miR-423-5p to counteract SAA1-mediated suppression. These engineered EVs, with a size distribution characteristic of small EVs, effectively targeted injured hepatocytes and significantly downregulated SAA1 expression in vivo ( P < 0.0001). Mechanistically, we demonstrated that suppressing SAA1 restores VCP-dependent mitophagy flux, reduces hepatic lipid deposition, and triples Ki67 + hepatocyte proliferation compared to controls. The therapeutic efficacy was further validated in free fatty acid (FFA)-treated primary hepatocytes and primary hepatocyte–derived epithelial organoid (PHLO) models of steatosis. Furthermore, analysis of human tissue microarrays confirmed the clinical relevance of the miR-423-5p/SAA1 axis. This preclinical study establishes a dual-functional engineered-EV platform that leverages SAA1 suppression and metabolic modulation and identifies the miR-423-5p/SAA1/VCP axis as a candidate therapeutic pathway; further dose, safety, manufacturing, and large-animal evaluation is required before clinical translation.
Authors
- Beng Yang
- Yuqi Huang
- Charlie C. Xiang (ORCID: https://orcid.org/0000-0002-8194-2483)
- Yingchen Huang
- Shengchen Hu
- Xiao Xu
- Xun Qiu
- Ning Zhang
- Qiang Wei
- Di Lu
- Jun Pan
- Hanqing Liu
- Xinyang Zhong
- Yunguo Lei
Institutions
- Zhejiang Chinese Medical University (CN)
- Hangzhou Medical College (CN)
- Zhejiang University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12951-026-05198-0
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00